Abstract:BACKGROUND:Survivin is known to be overexpressed in various human malignancies, including pancreatic cancer, and mediates cancer cell proliferation and tumor growth, so the regulation of this molecule could be a new strategy for treating pancreatic cancer. In this study, short hairpin RNAs (shRNAs) specific to survivin were introduced into human pancreatic cancer Patu8988 cells to investigate the inhibitory effects on survivin expression and cell proliferation in vitro and in vivo.METHODS:Three kinds of shRNA specific to the survivin gene were designed and cloned into eukaryotic expression plasmid pGenesil-1 vector. Subsequently the recombinant plasmids were transfected into human pancreatic cancer Patu8988 cells with lipfectamineTM 2000 reagent. The mRNA and protein expressions of survivin in the transiently transfected Patu8988 cells were determined by RT-PCR, flow cytometry, and Western blotting analysis. The proliferation inhibition rates of stably transfected Patu8988 cells were determined by MTT assay. The antitumor activities of the three kinds of survivin-shRNA plasmids were evaluated in BALB/c nude mice inoculated with Patu8988 cells and bearing human pancreatic cancer.RESULTS:The three survivin-shRNA plasmids named pGenesil-1-survivin-1, pGenesil-1-survivin-2 and pGenesil-1-survivin-1+2 (with double interfering RNA sites) were successfully constructed, and were confirmed by restriction enzyme cutting and sequencing. At 48 hours after transfection, the expression of survivin mRNA and protein was inhibited in Patu8988 cells transfected with pGenesil-1-survivin-1, pGenesil-1-survivin-2, and pGenesil-1-survivin-1+2 when compared with that of either pGenesil-1-NC (with scrambled small interfering RNA) transfected cells or control cells (P<0.05). The MTT results showed that the proliferation rates of Patu8988 cells stably transfected with survivin-shRNA plasmids were reduced when compared with that of either pGenesil-1-NC transfected cells or control cells (P<0.01). Furthermore, when Patu8988 cells stably transfected with survivin-shRNA were injected into BALB/c nude mice, tumor growth was dramatically lower and the tumor was smaller than that of either pGenesil-1-NC transfected cells or control cells (P<0.01). The inhibitory effect of pGenesil-1-survivin-1 was the best among the three kinds of survivin-shRNA plasmids, but no combination of inhibitory effects was found in pGenesil-1-survivin-1+2.CONCLUSIONS:shRNAs specific to survivin have gene silencing effects and inhibit pancreatic cancer cell proliferation. shRNA activity against survivin could be of potential value in gene therapy for pancreatic cancer. However, shRNAs with double combining sites did not significantly enhance the interference compared with single site shRNAs, therefore further studies on this are needed.

Polymerase Synthesis and Potential Interference of a Small-Interfering RNA Targeting Hpim-2.

Interfering Efficacy of Sirnas Synthesized in Vitro with T7RNA Polymerase Targeted to Hpim-2

An Artificial Mirna Against Hpse Suppresses Melanoma Invasion Properties, Correlating With A Down-Regulation Of Chemokines And Mapk Phosphorylation

Silencing of HPV11ET gene expression by different RNA interference technology

[Influence of RNA Interference on MSI-2 Gene in THP-1 Cell and Expression of NUMB].

Effects of selective inactivation of DNA-PKcs gene with small interfering RNA on radiosensitivity of human pancreatic carcinoma cell line

siRNA-mediated silencing of BC047440 gene inhibits proliferation of human HepG2 cell

Construction of the recombinant adenovirus mediated short hairpin RNA to silence Polo-like kinase 1 and its biomedical application

The Study of Specific Inhibition of Mutant K-ras Gene Expression by Short Interfering RNAs in Human Pancreatic Carcinoma Cell PANC-1

Sirna Mediated Inhibition of Pancreatic Tumor Growth in Vitro and in Vivo

Inhibitory effect of PTI--1(PC--3) on PC--3 cell line by using short--hairpin siRNA expression vector pEGFP/U6 {\sl in vitro}

Construction of Targeting-Skp2 Shrna Plasmids and Observation of Their Inhibitory Effect on Tca8113 Cells

Rna Interference-Mediated Inhibition of Endogenous Survivin Expression in Hepatocarcinoma Cell

Therapeutic Silence of Pleiotrophin by Targeted Delivery of Sirna and Its Effect on the Inhibition of Tumor Growth and Metastasis

Knockdown of survivin expression by small interfering RNA suppresses proliferation of two human cancer cell lines.

Growth Inhibition Induced by Short Hairpin RNA to Silence Survivin Gene in Human Pancreatic Cancer Cells.

Silencing of hdm2 oncogene by siRNA inhibits p53-dependent human breast cancer

[Inhibition of Growth and Proliferation of Hep-2 Cells by Targeting Human Telomerase Reverse Transcriptase Mrna Using RNA Interference Technology].

RNA Interference, A Potential Strategy for Isoform-Specific Phosphatidylinositol 3-Kinase Targeted Therapy in Ovarian Cancer

Construction of Sirna Expression Plasmid Targeting Mitogen-Activated Protein Kinase and Its Effects on Cell Cycle and DNA Methylation in a Human Colon Cancer Cell Line

Stable RNA interference of hexokinase II gene inhibits human colon cancer LoVo cell growth in vitro and in vivo.